Editor for The Biotech Forum (www.biotechforumsa.com), the #2 subscribed to Marketplace investment service offered through SeekingAlpha. Top 5% ranked analyst (TipRanks) 2013 through first half of 2015. Daily contributor for Real Money Pro. Hedge fund manager from 2008 to 2011. Previously technology executive at Fortune 100 firm for a decade. For Free weekly investment reports on small, attractive biotech stocks just register at www.bretjenseninvests.com
Marc has more than thirty years of business ownership, investment, and financial management experience. In the beginning Radow was the founder of Class Travel, a global hospitality company and then with the Roxi Group, a pioneering manufacturing firm. From mid 2000’s Radow served as managing member of JAGR; investment and real estate development companies. From 2011 through the present, Radow served as trader responsible for all operations, investment services and client relations activities of JAGR Capital, an investment advisory firm and is currently the President of Veni Capital Directors, Inc., the Investment Advisor for the hedge fund the Vici Partners, LP.
More Info on Marc, visit: http://radow.net/ and to subscribe to his blog, Market Insight, directly visit: http://radow.net/subscriptions/
Just another guy with a day job and an obsession with the stock market... my goal is to achieve FI (financial independence) sooner rather than later.
My biggest successes have been in the biotech arena (over $300k personal portfolio profits), while my biggest losses have been due to overconfidence and a failure to adequately heed the bear thesis on my picks.
Most of the companies I investigate are growth or turnaround stories, although I do search for dividend stocks poised to outperform for my passive income portfolio.
Readers will notice that I group my stock picks by time frame (when I expect potential outperformance could occur)- near, medium, or long term.
As always, all posts are my personal opinion. None of my material should be considered as investment advice, as readers must make their own decisions based on their own financial situations or are encouraged to utilize an investment professional (CFP, etc). Trading and investing in stocks can be very risky, and investors can lose up to 100% of principal in the event of adverse circumstances. By reading my material readers are agreeing to the above and assuming all responsability for their own investment decisions.
Vincent Tizono is a privately capitalized speculator and investor who graduated summa cum laude with a Bachelor of Science from Rocky Mountain College. He's a former Edward Jones Financial Advisor who worked at Edward Jones Headquarters, in St. Louis, Missouri, handling multiple offices in transition. The cumulative assets, for the team that he helped to lead, totaled over 400 million dollars in assets under care. Lastly, he managed his own branch office in Coeur d'Alene, Idaho.
“No man so wise that he may not easily err if he takes no other counsel than his own. He that is taught only by himself has a fool for a master”-Ben Johnson
"There is nothing so disastrous as a rational investment policy in an irrational world" - John Maynard Keynes
"Amateurs care about how much they can make, but professionals care about how much they can lose" - Various Legends
Influences: Marty Schwartz, Charlie Munger, Richard Dennis, Philip A. Fisher, Benjamin Graham, and Peter Lynch
My advice for anyone that is seeking to make a living via speculation or investing: Risk management is more important than methodology and knowing what you don’t know is more important than what you do know. Furthermore, evolution has equipped us with instincts geared for the Savanna and not the market, so be bloodless in your disposition and emotionless in the application of your strategies.
Intraday Mean Reversion of Sentiment
I am an individual investor was a strong passion and interest in Life Sciences. I am a recent contributor to Seeking Alpha and hope to write a lot more. I will be talking mainly about small cap bio companies that I believe have value along with industry outlooks.
-I have been investing since the fall of 2008 and invested through one of the most difficult investing periods in history and know the importance of dividend growth and stability during those times as well as during the good times. I started writing for Seeking Alpha at the end of 2011 and I have been successful with the companies I write about, which is shown by my high TipRanks success rate (Link Below). https://www.tipranks.com/bloggers/brad-kenagy
Brian is the founder of Investor in the Family and Online Investor Conference.
At Investor in the Family (http://investorinthefamily.com/), Brian's goal is to help protect investors from making big mistakes that jeopardize their portfolios and financial futures.
The DIY Investing Summit (http://diyinvestingsummit.com/) was created to help link self-directed investors with carefully filtered and proven investing professionals to help save investors both time and money while building a portfolio that outperforms.
If you'd like to connect or learn more, please feel free to send a private message via Seeking Alpha platform.
Former broker, now an independent analyst/writer on Seeking Alpha and founder and editor of the Growth Stock Forum. Focusing on small-cap, mid-cap and biotech stocks. Looking for substantial sales and earnings growth potential and seeking the best risk-adjusted returns from my stock selection. Taking advantage of medium to long-term momentum.
My articles represent my personal opinion and analysis and should not be regarded as investment advice in any way. Readers and subscribers should do their own due diligence and/or consult their financial advisor before making decisions to buy or sell securities. Trading and investing include risks, including loss of principal.
Exclusive research: http://seekingalpha.com/author/oneil-trader/research
Vijar Kohli has a decade of experience in the investment world. He is currently the Portfolio Manager of Golden Door Asset Management, a registered investment adviser, specializing in customized separate account management for individuals and businesses.
He currently lives in New Jersey and works in New York.
Visit his site at http://www.goldendoorasset.com
The Insiders Forum focus is on small and mid-cap stocks that insiders are buying. Some studies have shown that equities with heavy insider purchases outperform the overall market over time. The portfolio managed by Bret Jensen, consists of 15 top stocks in different sectors of the market that not only are attractively valued but have had some significant insider purchases in recent months. Our goal is to outperform the Russell 2000 (the benchmark) over time. The Insiders Forum is also a sounding board for new investments in attractively priced equities where insiders are stepping up to the plate.
Mark D. Hines founded Blue Harbinger Research to help investors identify exceptional investment opportunities while avoiding the high costs and conflicts of interest that are prevalent throughout the industry. Additional free reports and a premium research service are available at BlueHarbinger.com. Mr. Hines is also a registered Investment Advisor. If you are ever in the Naperville, IL, USA area, Mark is happy to meet you at a local coffeehouse to talk about investments. Please feel free to get in touch.
Frances Coppola worked in banking for 17 years as a business analyst and project manager, running business and systems projects for (among others) RBS, Nat West, HSBC, Midland Bank and SBC Warburg (now UBS). Her banking experience encompasses retail and investment banking, front office, operations and settlement, but her particular area of expertise is financial control and risk management. She is particularly proud of the fact that RBS still produces its financial and regulatory reporting using a group consolidation system that she designed.
Frances is now a writer and commentator on banking, finance and economics. Her blog Coppola Comment is widely read and her writing has featured on the Financial Times, City AM, The Economist. The Guardian and a range of online publications. She also writes for the online magazine Pieria and occasionally for the ICAEW, and she is a frequent commentator on banking matters for the BBC.
Frances has an MBA from Cass Business School with a specialism in finance and risk management. And since financial people can be creative too, Frances is also a professional singer and singing teacher. She has a B.Mus from London University and is an Associate of the Royal College of Music. She also has two teenage children and not much time to do the garden any more!
Chris (email@example.com) is an Hon B.Sc graduate (with distinction) in Science and Economics with over 15 years in investing experience. He holds a PMP (Project Management Professional) designation. TipRanks Top 100 Blogger of 2015 (also 2013, 2014). Seeks undervalued, unappreciated value stock ideas. Follows Warren Buffett's mantra: do not lose money. For a better mobile experience on Seeking Alpha click on the top right menu icon on most browsers and select "request desktop site".
Over 35 years of investing in individual stocks. Extensive business experience with small to mid-size companies, including as CEO. Many hundreds of blog posts on financial and economic matters since 2008. Focus on value with catalysts for upside price action; and biotech. Background as a physician and pharmaceutical inventor and entrepreneur, however focus now is global and involves almost all economic categories.
My name is Dr Kanak Kanti De, MBBS, MD, PhD, retired medical practitioner, cancer survivor, healthcare sector investor, over 30 years' experience in the sector both in India and the United States. I write/have written on Motley Fool, SeekingAlpha, Benzinga, and on Forbes. I am consistently ranked high on TipRanks, although I don't like their ranking system. My portfolio has consistently beat the various indices for years. Email me to discuss my articles, or for just an adda (Bengali for informal chat) firstname.lastname@example.org.
Stephen has over 13 years trading his own brokerage account and providing capital market consulting services to both institutional buy-side clients and retail market participants. He cut his teeth trading the 2007-08 financial crisis, which taught invaluable lessons on market psychology and reinforced his natural contrarian tendencies. Ever the one to buck popular convention and play “devil’s advocate,” Stephen actively makes bets against conventional wisdom and current market sentiment. In late 2015, he upped his investment in the joint brokerage account with his uncle to pursue his decade-long dream of running his own fund. He graduated class 08’ with a B.S. in Finance from UNLV and earned the Chartered Financial Analyst designation in 2015.
I am a psychologist at the University of Massachusetts/Amherst. I am on our campus’s Institutional Review Board, which must conclude that proposed studies involving human subjects are conducted ethically and are designed well enough so that any risks involved are justified by the likely benefits obtained.
I teach about analytical reasoning, leadership skills, reconciling apparently incompatible positions, designing, implementing, and evaluating policies, and how to critically evaluate competing health claims based on the samples studied and methods of data collection and analysis used.
Most of my investments involve owning medical industry stocks.
Jeff is the President of NewArc Investments Inc., manager of both individual and institutional investments. Jeff is a registered investment advisor, and portfolio manager for NewArc's investment programs. Jeff is a former college professor with a hands-on, real world attitude. His quantitative modeling helped inform state and local officials in Wisconsin for more than a decade. A Public Policy analyst, he taught advanced research methods at the University of Wisconsin, and analyzed many issues related to state tax policy. Jeff began in the financial business as Research Director for trading firm at the Chicago Board Options Exchange. He investigated anomalies in the standard option pricing models, taught classes for beginning options traders, and developed new forecasting techniques. In 1991 he established a general research consultancy, working with professional traders at all of the Chicago financial exchanges. In 1998 he started NewArc Investments, Inc. Jeff has a commitment to the specific needs of individual investors. It is not a one-size-fits all approach, but one that emphasizes the unique circumstances of each client. Jeff also serves on the board of two small technology companies (currently Chairman at one). He is occasionally as an expert witness in legal cases involving financial markets and hedging.
Surgeon with a highly varied background. Mixture of buy and hold equities and higher risk securities and LEAP calls.
The picture is James K. Polk; one of our most successful and underrated presidents. Ran for office stating he would accomplish 4 things. Accomplished all four, died shortly after his term completely exhausted.
Mr. Berger is the creator and developer of the YDP screening tool, a chart system and its analysis for screening and monitoring dividend income equity investments. The recipient of Seeking Alpha's Outstanding Performance Award, he also has been Seeking Alpha's #3 ranked Author for Income Investing Strategy & #4 for Utilities.
20 years of sitting in the board room gives me unique insights into Oil & Gas investments and corporate deal making in general. Additionally, he offers a Premium Research subscription service for boosting income while reducing market risk using covered option writing on a dividend income equity portfolio.
Residing in Brazil gives me a local's inside view on the pulse of its economy, politics, investment climate and breaking news. A view of my front yard is available here.
A former Chief Operating Officer, Director, Vice President and General Manger of Oil and Gas for Southern Pacific's Oil and Gas Operations, Business owner, geologist, and cribbage player, I've been an investor for over 48 years (started young at 13) and learned my lessons the way that makes them stick, by hard knocks and both big and little mistakes. Hopefully I can share some of those lessons with others.
I am an American expatriate that decided to retire at age 57 in 2009 and now live in Brazil. As an early retiree I invest for income and manage portfolio risk by screening for strong and reliable historic data along with favorable fundamental and technical current trends.
I spend 6 months/year living at home in Brazil and 6 months/year traveling the world. I have structured my financial positions so that I live virtually tax free with much of my income exempt from US tax since I live ex patriot and a lot of my US derived income over the annual ex-patriate exemptions is held in my tax free ROTH and tax deferred IRA/SIMPLE plans. This enables my tax savings to pay for my 6 months of annual traveling :) .
My investing is for income and appreciation with a balance of low to moderate short term risk and low long term risk. To accomplish this I use quality dividend payors with a long track record of steady or increasing dividends along with slowly appreciating equity prices. I target a 6 to 9 % yield and almost exclusively require a minimum history of 5 years of steady/increasing dividends and no decreases in dividend ever or at least past 10 years. I diversify through sector, country and currency unit the stocks are traded in, and security type (equity, royalty trust, REIT, mlp, etf, and ADRs).
I use covered call writing to enhance my portfolio yield with no added risk. In fact, it lowers the risk substantially. Once I identify a stock I want to own and an entry price for it, I write cash covered puts at or below that entry price (with a minimum of 1%/month time premium. Thus i obtain at least a 12% annualized yield before compounding just from the option premium.
Likewise, I use the sale of cash covered puts to generate income and and generally get an entry point at 5 to 10% below my acceptable entry level price if/when the put stock does get presented. Thus my strategy provides a 12% pre compound yield on cash and entry into stock purchases at a 5 to 10% discount from "retail".
Because I only select stocks that I am willing to hold long term for their reliable dividend yields of > 6%, I am not concerned much with market volatility or short/midterm risk. Indeed, market volatility is my friend since it increases the premiums paid on the options I sell. I also selectively sell covered calls on positions I hold long so as to add to my yield that way while not taking on any additional risk.
This strategy has kept me happily living off my portfolio income and traveling 1/2 the year while my portfolio has been slowly increasing in value even after my harvesting income for living expenses. Of course my income will incrementally increase when social security kicks in for me in a few more years and I may then slightly mofidy my goals and strategies.
Readers can get an e-mail once a day from Seeking Alpha that lists all newly published articles of ALL the authors they follow in a single e-mail. To get these updates:
- a - Click "Alerts" along the top menu tab (just left of the green PRO tab)
- b - Scroll all the way down, and check the box for "author alerts" (2nd box from the bottom)
- c - Then you'll be notified by Seeking Alpha once per day of new articles by all authors you follow (in a single e-mail)
Biophile6 is an award winning small business person, chemist, biochemist, and microbiologist (Emory - Ph.D.; Harvard - Post Doc) with professional interest in clinical informatics, small business management, biotech valuation,and drug development. A former prep school chemistry instructor and cross country runner/skier, his professional goal is to organize the complex disciplines of drug compound identification and target validation, especially as regards bacterial and viral pathogens, for the purposes of clinical infection control, microbial pathogen surveillance, diagnostics, and vaccine development. Side interests include small business management, biofuels, metabolic pathway design, natural products chemistry, thorium nuclear, material coatings, transition metals and mining. He designs informatics algorithms, with an eye to devise new principles upon which to order research information meaningfully. These same principles governing the evolution of life can inform the evolution of companies.
Wall Street Breakfast, Seeking Alpha's flagship daily business news summary, is a one-page summary that gives you a rapid overview of the day's key financial news. It's designed for easy readability on the site or by email (including on mobile devices), and is published before 7:00 AM ET every market day.
Wall Street Breakfast readership of over 900,000 includes many from the investment-banking and fund-management industries.
Sign up here to receive the Wall Street Breakfast in your inbox every business day: http://seekingalpha.com/account/email_preferences
Jonathan Moreland is the founder and Director of Research at InsiderInsights.com, which produces the weekly InsiderInsights Newsletter, and offers institutional strength, real-time insider data and analytics via a subscription Data Module and APIs. He is also principal of Insider Asset Management llc, a registered investment advisor in New York State, and a past contributor to TheStreet.com, Minyanville, and other financial outlets.
A fundamental analyst with an MBA in finance, Mr. Moreland identified insider data over 25 years ago as an excellent first screen to determine where to focus his research efforts. He is quoted frequently in the media for his insider analysis, and stock recommendations stemming from it. He is also author of Profit From Legal Insider Trading (Dearborn 2001), and has a new book due out with Wiley.
Mr. Moreland is currently on a mission to get investors to expect more from insider data than the commodity feeds they rely on from their Bloomberg terminals, Yahoo!Finance, and other financial websites.
INDEPENDENT Financial Advisor / Professional Investor- with over 30 years of navigating the Stock market's "fear and greed" cycles that challenge the average investor. Investment strategies that combine Theory, Practice and Experience to produce Portfolios focused on achieving positive returns over a period of time. Providing advice in helping to avoid the pitfalls and traps that wreak havoc on your portfolio with a focus on Income and Capital Preservation.
I manage the capital of only a handful of families and I see it as my number one job to protect their financial security. They don’t pay me to sell them investment products, beat an index, abandon true investing for mindless diversification or follow the Wall Street lemmings down the primrose path. I manage their money exactly as I manage my own so I don’t take any risk at all unless I strongly believe it is worth taking.
Blogging here on SA is part of my research. I write to find out what I think.
I invite you to join the family of satisfied clients send an e-mail :email@example.com
Have retired after having an over 20 year successful career as a Senior Financial Analyst for a Fortune 500 company where I performed due diligence on acquisitions, potential acquisitions as well as contributed to the completion of annual reports and preparing materials for the investment community. I am a bit rusty but I realized over the last 7 years that my analytical skills and niche in the the healthcare industry, specifically Biotechs, lends quite naturally to trading and covered calls. I am generally long, but the point of this business is to make money so I have developed my own method to take profits. Most recently I hold positions in $COR, $MAIN, $EXEL, $LXRX, $AKAO, $DYAX, $DVAX, $,GILD, $CELG, $LGND, $XON, $IRMD, $MITK, $ATVI, $AFFX, $TEVA,$PACB, $BPMC, $RLYP, $EGRX, $THLD, $ADXS, $O, $MITT,$T, $VZ, $VTR, $LMAT, $MO& $ED, $AAPL, $AMBA, $CRTO, $KR, $NKE, $DFS $SBUX just to name a few. I have been a consultant and consumer in the healthcare/biotech market for years and have been able to seek out growth opportunities and likely and successful buyout candidates with 15% of my portfolio dedicated to late-stage biotech specs and have achieved tremendous success, most recent examples are $SURG & $AFFX. Overall, however I do maintain a diversified portfolio and choose dividend paying stocks that offer both growth and income, specifically $MO, $TEVA, $BOH, $SBUX, $T, $HBI, were purchased during corrections providing outstanding yield & growth. I do utilize options very selectively to generate additional income, a strategy I that I find too risky during such volatility as we have experienced since the summer of 2015 through the drop we are currently experiencing currently. I am always re-evaluating my holdings, taking some profits, allowing for a larger cash position and taking advantage of the low prices of quality stocks. Biotech's seem to have been hit the hardest during these rotational corrections however if well researched, there is an excellent reward /risk profile and there is money to be made as long as spec investments are kept within your budget & there is a realistic understanding of the potential to lose it all. I both make and advise buys, as best as I can, to protect against the increased global instability & volatility this market is experiencing, regardless of the industry or company, that no one is immune from large losses so I don't invest what I can't afford to lose. Having had more than a few sleepless nights over the last 6-8 mos. in particular, my motto is if it keeps you up at night, rebalance!. I am always open to here other contributors' views whether or not they match my own, I believe we all have the ability to learn something valuable form each other.
Seeking Alpha's business development team is responsible for relationships with partner websites, investment and trading platforms for professional and retail users and major media companies. The purpose of this profile is to allow us to share details of new partnerships and updates on longstanding relationships. Guy Cohen - Director of Business Development: firstname.lastname@example.org Adam Jackson - Director of Content Partnerships: email@example.com Rachael Granby - Director of Product Development & Enhancement: firstname.lastname@example.org
Managing personal and family funds since 1971. Curiosity is the first step to profitability. Constantly researching opportunities. Retired at age 51 then married my long time sweetheart at age 58. Trade daily, rarely short individual stock but will hedge using inverse 2x ETFs/ETNs. B.A. M.P.A. J.D Phi Kappa Phi